Nbty Inc (NTY) Financial Statements (2024 and earlier)

Company Profile

Business Address 90 ORVILLE DR
BOHEMIA, NY 11716
State of Incorp. DE
Fiscal Year End September 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2015
9/30/2014
9/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments139199
Cash and cash equivalents139199
Receivables176172
Inventory, net of allowances, customer advances and progress billings853740
Inventory853740
Other current assets79 
Prepaid expense and other current assets79
Deferred tax assets  
Other undisclosed current assets 2924
Total current assets:1,2761,212
Noncurrent Assets
Property, plant and equipment597572
Intangible assets, net (including goodwill)2,9553,221
Goodwill1,1631,261
Intangible assets, net (excluding goodwill)1,7921,960
Other noncurrent assets49 
Prepaid expense and other noncurrent assets68
Total noncurrent assets:3,6023,861
TOTAL ASSETS:4,8785,073
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities530549
Taxes payable 3717
Employee-related liabilities 4453
Accounts payable228259
Accrued liabilities221220
Debt00
Other undisclosed current liabilities (81)(70)
Total current liabilities:449479
Noncurrent Liabilities
Long-term debt and lease obligation, including:2,1582,158
Long-term debt, excluding current maturities 2,1582,158
Capital lease obligations  
Other undisclosed long-term debt and lease obligation  
Liabilities, other than long-term debt761811
Deferred tax liabilities, net708751
Other liabilities5359
Total noncurrent liabilities:2,9192,969
Total liabilities:3,3693,448
Equity
Equity, attributable to parent1,5091,625
Additional paid in capital1,5611,557
Accumulated other comprehensive loss(29)(14)
Retained earnings (accumulated deficit)(23)81
Total equity:1,5091,625
TOTAL LIABILITIES AND EQUITY:4,8785,073

Income Statement (P&L) ($ in millions)

9/30/2015
9/30/2014
9/30/2013
Revenues
(Revenue, Net)
3,2273,177
Cost of revenue(1,896)(1,876)
Cost of goods and services sold(1,844)(1,795)
Gross profit:1,3301,301
Operating expenses(1,207)(957)
Other undisclosed operating loss (21)(14)
Operating income:103330
Nonoperating income (expense)(1)2
Loss, foreign currency transaction, before tax  
Interest and debt expense (136)(152)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 5
Income (loss) from continuing operations before income taxes:(34)184
Income tax expense(10)(55)
Income (loss) from continuing operations:(44)129
Income (loss) before gain (loss) on sale of properties:(44)129
Net income (loss) available to common stockholders, diluted:(44)129

Comprehensive Income ($ in millions)

9/30/2015
9/30/2014
9/30/2013
Net income (loss):(44)129
Other comprehensive income  
Comprehensive income (loss):(44)129
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(16)5
Comprehensive income (loss), net of tax, attributable to parent:(60)134

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: